How CarnaLife is Helping Curb Lifestyle Diseases
January 19, 2019 3:19 pm
Civilization diseases, commonly known as lifestyle diseases have been with us for hundreds of years. These are the diseases which are caused by the way people live their lives. The most commonly occurring lifestyle diseases are caused by consumption of alcohol, drugs, and smoking. The lack of physical activity and unhealthy eating habits is also a reason for such diseases. This also includes the increased consumption of meat, dairy products, vegetable oils, sugary foods, junk food, and processed foods.
The most common diseases that occur due to poor lifestyle include heart disease, obesity, type II diabetes, and stroke. The rise of Industrialization has also been a major factor directly related to the increase in lifestyle diseases. These include
- Alzheimer’s disease
- Chronic liver disease or cirrhosis
- Chronic obstructive pulmonary disease
- Type II diabetes
- Heart disease
- Metabolic syndrome
- Chronic renal failure
- Vascular dementia
A lot of lifestyle diseases have their roots due to the popularization of substances through popular culture. Through movies and mainstream media, people are exposed to alcohol consumption, smoking of cigarettes and drug use.
These diseases can be prevented by stopping the use of the substances or food that is causing the problem. Although in many cases, the disease is recognized much later in its development, which makes it significantly harder to cure.
There is an increasing need to educate people, especially the younger population about the dangers of lifestyle diseases.
MedApp UK Ltd is an official provider and distributor of MedApp SA technology called Analytical telemedicine system CarnaLife. Medapp UK Ltd is also the official entity involved in the preparation and execution of the ICO project. It is an innovative company offering unique, new-generation telemedicine solutions. Telemedicine, based on technology that enables a patient’s health condition to be monitored from a distance, is one of the fastest-growing industries in the world.
The versatile nature of our core product means that it can find abnormalities not only in cardiology, but also in diabetes, dietetics, civilization diseases, and chronic illnesses.
There are countless examples around the world where comparable achievements have required many years of work. Our effectiveness results mainly from the conscious use of the latest Microsoft technologies such as cloud computing, artificial intelligence, and cross-platform software.
This helps in quicker and accurate diagnosis of diseases and the AI helps in early detection of future diseases.
It is possible to live longer and prevent ourselves from future civilization diseases if we start today. Specialists are present across the globe – we aim to provide access to the best scientists, doctors, and healthcare providers to each and every human being.
To become a part of CarnaLife, please visit: www.CarnaLife.io